These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17724260

  • 1. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.
    Juonala M, Viikari JS, Alfthan G, Marniemi J, Kähönen M, Taittonen L, Laitinen T, Raitakari OT.
    Circulation; 2007 Sep 18; 116(12):1367-73. PubMed ID: 17724260
    [Abstract] [Full Text] [Related]

  • 2. Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study.
    Päivä H, Kähönen M, Lehtimäki T, Alfthan G, Viikari J, Laaksonen R, Hutri-Kähönen N, Laitinen T, Taittonen L, Raitakari OT, Juonala M.
    Atherosclerosis; 2010 Oct 18; 212(2):512-5. PubMed ID: 20655043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR.
    J Appl Physiol (1985); 2007 Jan 18; 102(1):63-71. PubMed ID: 16946027
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early childhood hospitalisation with infection and subclinical atherosclerosis in adulthood: the Cardiovascular Risk in Young Finns Study.
    Burgner DP, Sabin MA, Magnussen CG, Cheung M, Sun C, Kähönen M, Hutri-Kähönen N, Lehtimäki T, Jokinen E, Laitinen T, Viikari JS, Raitakari OT, Juonala M.
    Atherosclerosis; 2015 Apr 18; 239(2):496-502. PubMed ID: 25721701
    [Abstract] [Full Text] [Related]

  • 10. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
    Vladimirova-Kitova L, Deneva T, Angelova E, Nikolov F, Marinov B, Mateva N.
    Clin Physiol Funct Imaging; 2008 Nov 18; 28(6):417-25. PubMed ID: 18798847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG.
    Clin Sci (Lond); 2001 Feb 18; 100(2):161-7. PubMed ID: 11171285
    [Abstract] [Full Text] [Related]

  • 13. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
    Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, Home PD.
    Cardiovasc Diabetol; 2009 Jun 01; 8():27. PubMed ID: 19486510
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
    Ardigo D, Stüehlinger M, Franzini L, Valtueña S, Piatti PM, Pachinger O, Reaven GM, Zavaroni I.
    Eur J Clin Invest; 2007 Apr 01; 37(4):263-9. PubMed ID: 17373961
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.